FDAnews
www.fdanews.com/articles/132331-abiomed-gets-conditional-approval-for-study-on-reducing-heart-muscle-damage

Abiomed Gets Conditional Approval for Study on Reducing Heart Muscle Damage

December 2, 2010
Abiomed, Inc. … Thursday announced it has received conditional approval from the U.S. Food and Drug Administration to begin MINI-AMI, a prospective, randomized, controlled multi-site trial to assess the potential role of the Impella 2.5 in reducing infarct size in patients with ST-elevation.
TradingMarkets